Rothschild Investment Has Decreased Honeywell Intl (HON) Holding By $1.59 Million; Harvard Bioscience (HBIO) Shorts Decreased By 3.41%

May 26, 2018 - By Sherry Myers

Honeywell International Inc. (NYSE:HON) Logo

Rothschild Investment Corp decreased Honeywell Intl (HON) stake by 15.56% reported in 2017Q4 SEC filing. Rothschild Investment Corp sold 10,390 shares as Honeywell Intl (HON)’s stock declined 5.96%. The Rothschild Investment Corp holds 56,392 shares with $8.65M value, down from 66,782 last quarter. Honeywell Intl now has $112.53 billion valuation. The stock decreased 0.28% or $0.42 during the last trading session, reaching $150.66. About 1.93M shares traded. Honeywell International Inc. (NYSE:HON) has risen 15.94% since May 26, 2017 and is uptrending. It has outperformed by 4.39% the S&P500.

Harvard Bioscience Inc (NASDAQ:HBIO) had a decrease of 3.41% in short interest. HBIO’s SI was 238,100 shares in May as released by FINRA. Its down 3.41% from 246,500 shares previously. With 145,800 avg volume, 2 days are for Harvard Bioscience Inc (NASDAQ:HBIO)’s short sellers to cover HBIO’s short positions. The SI to Harvard Bioscience Inc’s float is 0.81%. The stock decreased 2.81% or $0.125 during the last trading session, reaching $4.325. About 89,422 shares traded. Harvard Bioscience, Inc. (NASDAQ:HBIO) has risen 87.27% since May 26, 2017 and is uptrending. It has outperformed by 75.72% the S&P500.

Investors sentiment decreased to 1.11 in 2017 Q4. Its down 0.03, from 1.14 in 2017Q3. It dropped, as 42 investors sold HON shares while 490 reduced holdings. 154 funds opened positions while 439 raised stakes. 531.30 million shares or 5.59% less from 562.75 million shares in 2017Q3 were reported. Jones Financial Companies Lllp holds 0.02% of its portfolio in Honeywell International Inc. (NYSE:HON) for 45,778 shares. Wafra Advisory Group Ny holds 0.88% in Honeywell International Inc. (NYSE:HON) or 126,160 shares. North Star Investment Mngmt Corp has 6,894 shares. Bragg Advisors Inc invested in 0.81% or 36,571 shares. Liberty Mutual Asset Mngmt Inc accumulated 30,384 shares. Lmr Prns Limited Liability Partnership has 6,113 shares for 0.1% of their portfolio. Holderness Invests has 18,953 shares for 1.43% of their portfolio. Boston Advisors Lc holds 0.03% or 8,954 shares in its portfolio. Magnetar Limited Liability Company reported 0.01% of its portfolio in Honeywell International Inc. (NYSE:HON). Cls Invs Limited Liability Company accumulated 35 shares or 0% of the stock. Intrust Bancorporation Na reported 0.56% stake. Firsthand Cap Mngmt Incorporated invested in 0.18% or 1,580 shares. Wms Prtnrs Limited Liability Corp reported 0.08% in Honeywell International Inc. (NYSE:HON). Pinnacle Fincl Prns, a Tennessee-based fund reported 49,986 shares. Field Main Fincl Bank accumulated 3,740 shares or 0.55% of the stock.

Another recent and important Honeywell International Inc. (NYSE:HON) news was published by which published an article titled: “Honeywell declares war on fixed costs” on May 22, 2018.

Among 21 analysts covering Honeywell International Inc. (NYSE:HON), 17 have Buy rating, 0 Sell and 4 Hold. Therefore 81% are positive. Honeywell International Inc. had 97 analyst reports since July 30, 2015 according to SRatingsIntel. The firm has “Buy” rating by RBC Capital Markets given on Wednesday, December 13. The firm has “Outperform” rating by Oppenheimer given on Thursday, December 17. The firm has “Buy” rating given on Thursday, March 1 by Stifel Nicolaus. On Monday, October 10 the stock rating was maintained by RBC Capital Markets with “Outperform”. As per Tuesday, October 20, the company rating was maintained by S&P Research. The firm earned “Strong-Buy” rating on Friday, August 28 by Vetr. The firm earned “Buy” rating on Monday, May 29 by RBC Capital Markets. As per Monday, April 30, the company rating was maintained by Oppenheimer. RBC Capital Markets maintained Honeywell International Inc. (NYSE:HON) on Sunday, October 22 with “Buy” rating. The firm earned “Buy” rating on Thursday, October 19 by Cowen & Co.

Since February 14, 2018, it had 0 insider buys, and 2 sales for $874,731 activity. $448,440 worth of Honeywell International Inc. (NYSE:HON) was sold by PARDO JAIME CHICO /FA on Monday, February 26. Deily Linnet F also sold $426,291 worth of Honeywell International Inc. (NYSE:HON) on Wednesday, February 14.

Analysts await Honeywell International Inc. (NYSE:HON) to report earnings on July, 20. They expect $2.00 EPS, up 11.11% or $0.20 from last year’s $1.8 per share. HON’s profit will be $1.49 billion for 18.83 P/E if the $2.00 EPS becomes a reality. After $1.95 actual EPS reported by Honeywell International Inc. for the previous quarter, Wall Street now forecasts 2.56% EPS growth.

Rothschild Investment Corp increased At&T Inc Com (NYSE:T) stake by 92,131 shares to 345,108 valued at $13.42 million in 2017Q4. It also upped Celgene Corp Com (NASDAQ:CELG) stake by 5,300 shares and now owns 89,497 shares. Costco Wholesale Corp (NASDAQ:COST) was raised too.

More news for Harvard Bioscience, Inc. (NASDAQ:HBIO) were recently published by:, which released: “Harvard Bioscience Reports First Quarter 2018 Financial Results” on May 02, 2018.‘s article titled: “Harvard Bioscience Subsidiary Data Sciences International Launches Two Telemetry Implants to Enhance …” and published on May 01, 2018 is yet another important article.

Investors sentiment increased to 1.32 in Q4 2017. Its up 0.41, from 0.91 in 2017Q3. It is positive, as 3 investors sold Harvard Bioscience, Inc. shares while 16 reduced holdings. 8 funds opened positions while 17 raised stakes. 22.13 million shares or 3.01% more from 21.49 million shares in 2017Q3 were reported. Heartland Advsrs has invested 0.36% in Harvard Bioscience, Inc. (NASDAQ:HBIO). Earnest Prtnrs Ltd has invested 0% of its portfolio in Harvard Bioscience, Inc. (NASDAQ:HBIO). Royal Bankshares Of Canada owns 0% invested in Harvard Bioscience, Inc. (NASDAQ:HBIO) for 2,090 shares. Deutsche National Bank & Trust Ag, a Germany-based fund reported 23,266 shares. Vanguard Group has 0% invested in Harvard Bioscience, Inc. (NASDAQ:HBIO). Foundry Prtn Ltd Liability Corp invested in 0.1% or 731,345 shares. Gsa Prns Llp holds 195,857 shares or 0.04% of its portfolio. Moreover, State Street has 0% invested in Harvard Bioscience, Inc. (NASDAQ:HBIO). First Light Asset Management Limited invested in 4.2% or 4.64M shares. 36,385 are owned by Bancorporation Of New York Mellon Corporation. Axa owns 0% invested in Harvard Bioscience, Inc. (NASDAQ:HBIO) for 167,500 shares. Ny State Common Retirement Fund reported 73,782 shares. Woodmont Investment Counsel Limited Company has 176,091 shares. California Employees Retirement System holds 0% or 139,202 shares. Panagora Asset Management invested in 18,071 shares.

Among 3 analysts covering Harvard Bioscience Inc (NASDAQ:HBIO), 3 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Harvard Bioscience Inc had 4 analyst reports since July 28, 2015 according to SRatingsIntel. The company was initiated on Tuesday, July 28 by Benchmark. The firm has “Buy” rating given on Thursday, November 17 by Singular Research.

Harvard Bioscience, Inc. develops, manufactures, and markets scientific instruments, systems, and lab consumables used in life science basic research, drug discovery, and clinical and environmental testing. The company has market cap of $155.62 million. The firm offers cell and animal physiology products, such as syringe pump and peristaltic pump products, as well as a range of instruments and accessories, including surgical products, infusion systems, microdialysis instruments, behavior research systems, and isolated organ and tissue bath systems, as well as in vivo and in vitro electrophysiology recording, stimulation, and analysis systems for tissue, organ, and animal based lab research under the Harvard Apparatus, CMA Microdialysis, Panlab, Coulbourn, Hugo-Sachs, InBreath Bioreactor, MCS, TBSI, and HEKA brands. It currently has negative earnings. It also provides products for molecular biology labs comprising pipettes and pipette tips, gloves, gel electrophoresis equipment and reagents, autoradiography films, thermal cycler accessories and reagents, sample preparation columns, tissue culture products, and general lab equipment and consumables under the Denville Scientific and other brands.

Harvard Bioscience, Inc. (NASDAQ:HBIO) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: